title: Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype.
authors.forename: Shany
authors.initials: S
authors.lastname: Blum
authors.forename: Uzi
authors.initials: U
authors.lastname: Milman
authors.forename: Chen
authors.initials: C
authors.lastname: Shapira
authors.forename: Rachel
authors.initials: R
authors.lastname: Miller-Lotan
authors.forename: Lawrence
authors.initials: L
authors.lastname: Bennett
authors.forename: Maria
authors.initials: M
authors.lastname: Kostenko
authors.forename: Michele
authors.initials: M
authors.lastname: Landau
authors.forename: Shlomo
authors.initials: S
authors.lastname: Keidar
authors.forename: Yishai
authors.initials: Y
authors.lastname: Levy
authors.forename: Alexander
authors.initials: A
authors.lastname: Khemlin
authors.forename: Arman
authors.initials: A
authors.lastname: Radan
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Levy
mesh_terms: D000367:Age Factors; D000368:Aged; D000975:Antioxidants / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000453:epidemiology* / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics*; D004359:Drug Therapy, Combination; D005260:Female; D005819:Genetic Markers; D005838:Genotype; D006242:Haptoglobins / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012016:Reference Values; D018570:Risk Assessment; D012737:Sex Factors; D015996:Survival Rate; D016896:Treatment Outcome; D014810:Vitamin E / Q000627:therapeutic use*
chemical_list: D000975:Antioxidants; D005819:Genetic Markers; D006242:Haptoglobins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014810:Vitamin E